Last reviewed · How we verify

NCT04010201

A Registered Cohort Study on Brain Calcification

Recruiting now Last updated 23 September 2019
What this trial tests

trial in Brain Calcification in 2,000 participants. Currently enrolling.

Timeline
25 August 2019
Primary endpoint
31 December 2029
31 December 2079

Quick facts

Lead sponsorWan-Jin Chen
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment2,000
Start date25 August 2019
Primary completion31 December 2029
Estimated completion31 December 2079
Sites1 location across China

Conditions studied

Sponsor

Wan-Jin Chen

Who can join

Eligibility, any sex, with Brain Calcification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brain calcification is a common neuroimaging feature in patients with metabolic, neurological, or developmental disorders, infectious diseases, traumatic or toxic history, as well as in otherwise normal older people. To understand the clinical and genetic characteristics of brain calcification, we establish a cohort of brain calcification to follow up patients with brain calcification.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Wan-Jin Chen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04010201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing